Skip to main content

Find Clinical Trials

Home
Conditions
Lung Neoplasms

Clinical trial condition

Lung Neoplasms

Explore clinical trials studying Lung Neoplasms. Study availability and eligibility vary by location and protocol.

4,232 public trials 1,022 recruiting studies

Refine in advanced search Browse all conditions

Lung Neoplasms trial results

Completed

INC280 and Erlotinib Hydrochloride in Treating Patients With Non-small Cell Lung Cancer

NCT01911507

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: University of California, Davis Sacramento, California, United States

UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States

View Trial Details

Completed

Study of Nivolumab (BMS-936558) in Combination With Gemcitabine/Cisplatin, Pemetrexed/Cisplatin, Carboplatin/Paclitaxel, Bevacizumab Maintenance, Erlotinib, Ipilimumab or as Monotherapy in Subjects With Stage IIIB/IV Non-small Cell Lung Cancer (NSCLC) (CheckMate 012)

NCT01454102

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Ucla Los Angeles, California, United States

Yale University New Haven, Connecticut, United States

H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States

Johns Hopkins Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States

View Trial Details

Completed

A Phase I Trial of Vandetanib (AZD6474) and Selumetinib (AZD6244) for Solid Tumours Including Non Small Cell Lung Cancer (VanSel-1)

NCT01586624

Conditions: Bronchial Neoplasms, Cancer, Carcinoma, Bronchogenic, +9 more
Locations: Churchill Hospital Headington, Oxford, United Kingdom

Addenbrooke's Hospital Cambridge, United Kingdom

The Christie Hospital Manchester, United Kingdom

Freeman Hospital Newcastle, United Kingdom

View Trial Details

Completed

Study of Two Doses of Pembrolizumab (MK-3475) Versus Docetaxel in Previously Treated Participants With Non-Small Cell Lung Cancer (MK-3475-010/KEYNOTE-010)

NCT01905657

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations: Not specified

View Trial Details

Completed

Nab-Paclitaxel in Combination With Carboplatin as First-line Therapy in Patients With NSCLC

NCT02799862

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
Locations: iOMEDICO Freiburg im Breisgau, Baden-Wurttemberg, Germany

View Trial Details

Completed

Impact of eHealth Monitoring on Overall Survival in Patients With Metastatic NSCLC / Extensive-stage SCLC / Advanced TNBC Under First-line Treatment With Atezolizumab Plus Chemotherapy

NCT03911219

Conditions: Advanced (Locally Advanced and Inoperable or Metastatic), PD-L1 IC-positive TNBC, Bronchial Neoplasms, Carcinoma, Bronchogenic, +15 more
Locations: Onkologische Praxis im St. Marien-Krankenhaus Ahaus, Germany

Gesundheitszentrum St. Marien Amberg, Germany

Klinikum Arnsberg, Karolinen Hospital Arnsberg, Germany

MVZ am Klinikum Aschaffenburg Aschaffenburg, Germany

View all 92 locations

View Trial Details

Completed

Stereotactic Body Radiotherapy (RT) for Non-Small Cell Lung Cancer

NCT01480973

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations: Princess Margaret Hospital, University Health Network Toronto, Ontario, Canada

View Trial Details

Completed

Intracavitary Cisplatin-Fibrin Localized Chemotherapy After P/D or EPP for Malignant Pleural Mesothelioma

NCT01644994

Conditions: Adenoma, Lung Diseases, Lung Neoplasms, +12 more
Locations: University Hospital Zurich, Division of Thoracic Surgery Zurich, Canton of Zurich, Switzerland

View Trial Details

Completed

Phase II Study of Abraxane and Gemicitabine in Patients With Advanced Adenocarcinoma Non-Small Cell Lung Cancer Progressing After First-Line Platinum-Based Chemotherapy

NCT02303977

Conditions: Adenocarcinoma, Adenocarcinoma of Lung, Carcinoma, +8 more
Locations: Not specified

View Trial Details

Completed

A Study of Atezolizumab in Combination With Carboplatin Plus (+) Paclitaxel With or Without Bevacizumab Compared With Carboplatin+Paclitaxel+Bevacizumab in Participants With Stage IV Non-Squamous Non-Small Cell Lung Cancer (NSCLC)

NCT02366143

Conditions: Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +7 more
Locations: Ironwood Cancer & Research Centers Chandler, Arizona, United States

Arizona Oncology Associates Flagstaff, Arizona, United States

Southern CA Permanente Med Grp Bellflower, California, United States

Marin Cancer Care Inc Greenbrae, California, United States

View all 240 locations

View Trial Details